Literature DB >> 24643131

Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.

Jakk Wong1, Yvette M Piceno1, Todd Z DeSantis2, Madeleine Pahl3, Gary L Andersen1, Nosratola D Vaziri3.   

Abstract

BACKGROUND: Intestinal microbiome constitutes a symbiotic ecosystem that is essential for health, and changes in its composition/function cause various illnesses. Biochemical milieu shapes the structure and function of the microbiome. Recently, we found marked differences in the abundance of numerous bacterial taxa between ESRD and healthy individuals. Influx of urea and uric acid and dietary restriction of fruits and vegetables to prevent hyperkalemia alter ESRD patients' intestinal milieu. We hypothesized that relative abundances of bacteria possessing urease, uricase, and p-cresol- and indole-producing enzymes is increased, while abundance of bacteria containing enzymes converting dietary fiber to short-chain fatty acids (SCFA) is reduced in ESRD.
METHODS: Reference sets of bacteria containing genes of interest were compiled to family, and sets of intestinal bacterial families showing differential abundances between 12 healthy and 24 ESRD individuals enrolled in our original study were compiled. Overlap between sets was assessed using hypergeometric distribution tests.
RESULTS: Among 19 microbial families that were dominant in ESRD patients, 12 possessed urease, 5 possessed uricase, and 4 possessed indole and p-cresol-forming enzymes. Among 4 microbial families that were diminished in ESRD patients, 2 possessed butyrate-forming enzymes. Probabilities of these overlapping distributions were <0.05.
CONCLUSIONS: ESRD patients exhibited significant expansion of bacterial families possessing urease, uricase, and indole and p-cresol forming enzymes, and contraction of families possessing butyrate-forming enzymes. Given the deleterious effects of indoxyl sulfate, p-cresol sulfate, and urea-derived ammonia, and beneficial actions of SCFA, these changes in intestinal microbial metabolism contribute to uremic toxicity and inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643131      PMCID: PMC4049264          DOI: 10.1159/000360010

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  44 in total

1.  High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

Authors:  Vidya M Raj Krishnamurthy; Guo Wei; Bradley C Baird; Maureen Murtaugh; Michel B Chonchol; Kalani L Raphael; Tom Greene; Srinivasan Beddhu
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

2.  Bacterial ureases in uraemic men.

Authors:  C L Brown; M J Hill; P Richards
Journal:  Lancet       Date:  1971-08-21       Impact factor: 79.321

3.  Urea concentration in intestinal fluids in normal and uremic dogs.

Authors:  Y T Lee
Journal:  J Surg Oncol       Date:  1971       Impact factor: 3.454

4.  Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases.

Authors:  N D Vaziri; B Dure-Smith; R Miller; M K Mirahmadi
Journal:  Am J Gastroenterol       Date:  1985-08       Impact factor: 10.864

5.  Chronic kidney disease alters intestinal microbial flora.

Authors:  Nosratola D Vaziri; Jakk Wong; Madeleine Pahl; Yvette M Piceno; Jun Yuan; Todd Z DeSantis; Zhenmin Ni; Tien-Hung Nguyen; Gary L Andersen
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

6.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

7.  Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism.

Authors:  E A Smith; G T Macfarlane
Journal:  J Appl Bacteriol       Date:  1996-09

8.  Intestinal excretion of oxalate in chronic renal failure.

Authors:  M Hatch; R W Freel; N D Vaziri
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

9.  Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.

Authors:  Nosratola D Vaziri; Jun Yuan; Mahyar Khazaeli; Yuichi Masuda; Hirohito Ichii; Shuman Liu
Journal:  Am J Nephrol       Date:  2013-05-15       Impact factor: 3.754

Review 10.  Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

Authors:  Victoria Cachofeiro; Marian Goicochea; Soledad García de Vinuesa; Pilar Oubiña; Vicente Lahera; José Luño
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

View more
  185 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.

Authors:  Nosratola D Vaziri
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

Review 3.  Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?

Authors:  Cristiane Moraes; Natália A Borges; Denise Mafra
Journal:  Eur J Nutr       Date:  2016-01-30       Impact factor: 5.614

4.  Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.

Authors:  Yan Jun Li; Xiaochen Chen; Tony K Kwan; Yik Wen Loh; Julian Singer; Yunzi Liu; Jin Ma; Jian Tan; Laurence Macia; Charles R Mackay; Steven J Chadban; Huiling Wu
Journal:  J Am Soc Nephrol       Date:  2020-05-01       Impact factor: 10.121

Review 5.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 6.  Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

Authors:  Dorothy A Kieffer; Roy J Martin; Sean H Adams
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

7.  Urea hydrolysis by gut bacteria in a hibernating frog: evidence for urea-nitrogen recycling in Amphibia.

Authors:  James M Wiebler; Kevin D Kohl; Richard E Lee; Jon P Costanzo
Journal:  Proc Biol Sci       Date:  2018-05-16       Impact factor: 5.349

Review 8.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

Review 9.  Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.

Authors:  Alexander J Prokopienko; Thomas D Nolin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-09-20       Impact factor: 5.045

Review 10.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.